# AirNexis Therapeutics, Inc. — Form D

AirNexis Therapeutics, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-09. The offering totals $200.0M, of which $62.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-03-09
- Form: D
- Accession: 0002116194-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $200.0M
- Amount sold: $62.0M
- Remaining: $138.0M
- Investors: 13
- Date of first sale: 2026-01-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-575781

## Issuer

- Name: AirNexis Therapeutics, Inc.
- CIK: 0002116194
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 1001 PAGE MILL ROAD, PALO ALTO, CA, 94304
- Phone: (619) 604-7904

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Evan Caplan | Director | Palo Alto, CA |
| Jill Carroll | Director | Palo Alto, CA |
| Anna Chen | Director | Palo Alto, CA |
| Maria Fardis | Director | San Francisco, CA |
| James Li | Director | Palo Alto, CA |
| Colin Walsh | Director | Palo Alto, CA |
| Maria Fardis | Executive Officer | San Francisco, CA |
| James Li | Executive Officer | Palo Alto, CA |

## More

- [CIK 2116194 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2116194&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002116194-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.